Echocardiographic findings and plasma endothelin-1 levels in obese patients with and without obstructive sleep apnea
- 18 September 2015
- journal article
- research article
- Published by Springer Nature in Sleep and Breathing
- Vol. 20 (2) , 613-619
Abstract
Objective Obstructive sleep apnea (OSA) and obesity are increasingly prevalent worldwide. Both promote endothelial dysfunction contributing to systemic and pulmonary hypertension over time. Endothelin-1 (ET-1) plays a pivotal role in the development of pulmonary hypertension (PH). The aim of the present study was to assess the association between plasma ET-1 and echocardiographic findings in obese individuals with and without OSA, as well as in non-obese patients with OSA. Methods Ninety-seven subjects (56 males) were enrolled in the study. All subjects underwent the following tests: venous endothelin-1 levels, pulmonary function testing, and arterial blood gas analysis. All patients except controls underwent transthoracic echocardiography and portable testing for sleep-disordered breathing. Results Plasma ET-1 levels were significantly higher in obese patients, both with and without OSA (respectively, n = 30 (mean value, 268.06 ± 49.56 pg/ml) and n = 32 (mean value, 263.12 ± 65.26 pg/ml)), compared with non-obese patients with OSA or to healthy controls (respectively, n = 20 (mean value, 149.8 ± 23.09 pg/ml) and n = 15 (mean value, 152.3 ± 27.64 pg/ml); p < 0.0001). Pulmonary artery pressure (PAPs) in obese patients with OSA were significantly higher than in obese patients without OSA (p < 0.0001), while there was no statistical difference between PAPs of obese patients without OSA, compared with the group of non-obese OSA patients. Plasma ET-1 levels significantly correlated with systolic PAPs in obese patients both with and without OSA (respectively, n = 30, r = 0.385, p = 0.03567; n = 32, r = 0.3497, p = 0.0497). Conclusions Our study suggests that endothelin levels are more strongly associated with weight than the presence of sleep-disordered breathing, but pulmonary artery hypertension is associated with both weight and OSA.Keywords
This publication has 35 references indexed in Scilit:
- Obesity and Pulmonary Hypertension: A Review of Pathophysiologic MechanismsJournal of Obesity, 2012
- Pulmonary hypertension and right heart failure in heart failure with preserved left ventricular ejection fractionCurrent Opinion in Cardiology, 2012
- Circulating levels of vascular endothelial markers in obstructive sleep apnoea syndrome. Effects of nasal continuous positive airway pressureArchives of Medical Science, 2011
- Prevalence and Risk Factors of Pulmonary Hypertension in Patients With Elevated Pulmonary Venous Pressure and Preserved Ejection FractionThe American Journal of Cardiology, 2010
- Pathophysiology of Sleep ApneaPhysiological Reviews, 2010
- Frequency and Impact of Pulmonary Hypertension in Patients With Obstructive Sleep Apnea SyndromeThe American Journal of Cardiology, 2009
- Insulin resistance in pulmonary arterial hypertensionEuropean Respiratory Journal, 2008
- Exhaled and arterial levels of endothelin-1 are increased and correlate with pulmonary systolic pressure in COPD with pulmonary hypertensionBMC Pulmonary Medicine, 2008
- Circulating endothelin-1 concentrations in patients with chronic hypoxia.Journal of Clinical Pathology, 1995
- Quantitative assessment of pulmonary hypertension in patients with tricuspid regurgitation using continuous wave doppler ultrasoundJACC, 1985